Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
973.41B
Market cap973.41B
Price-Earnings ratio
50.34
Price-Earnings ratio50.34
Dividend yield
0.57%
Dividend yield0.57%
Average volume
5.55M
Average volume5.55M
High today
$1,032.80
High today$1,032.80
Low today
$1,008.19
Low today$1,008.19
Open price
$1,010.09
Open price$1,010.09
Volume
991.99K
Volume991.99K
52 Week high
$1,032.80
52 Week high$1,032.80
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 973.41B, Eli Lilly(LLY) trades at $1,029.65. The stock has a price-to-earnings ratio of 50.34 and currently yields dividends of 57.0%.

During the trading session on 2025-11-13, Eli Lilly(LLY) shares reached a daily high of $1,032.80 and a low of $1,008.19. At a current price of $1,029.65, the stock is +2.1% higher than the low and still -0.3% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 991.99K, versus its average volume of 5.55M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,032.80 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,032.80 and a low of $623.78.

LLY News

TipRanks 1h
Mangoceuticals Stock Soars on Deal to Sell Obesity Drugs for Eli Lilly, Novo Nordisk

Shares of Mangoceuticals (MGRX), the Texas-based telehealth company focused on men’s health, rose sharply in early trading on Thursday, climbing 24.43% to $2.19...

Simply Wall St 2h
Is Now the Time to Reassess Eli Lilly After 30.8% YTD Surge?

If you’re wondering whether Eli Lilly is a good buy at its current price, you’re not alone; everyone wants to know if there’s still value left after such a run-...

Is Now the Time to Reassess Eli Lilly After 30.8% YTD Surge?
TipRanks 2h
MeiraGTx reports Q3 EPS (62c) vs. (55c) last year

Reports Q3 revenue $410,000 vs. $10.9M last year. “Following the close of the third quarter, we are very pleased to have signed a strategic collaboration in oph...

Analyst ratings

76%

of 33 ratings
Buy
75.8%
Hold
21.2%
Sell
3%

More LLY News

TipRanks 3h
Eli Lilly price target raised to $1,171 from $1,090 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Eli Lilly (LLY) to $1,171 from $1,090 and keeps an Overweight rating on the shares. Follo...

TipRanks 3h
Mangoceuticals Partners with Eli Lilly and Novo Nordisk

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

TipRanks 3h
Mangoceuticals partner with Eli Lilly, Novo, provide access to Zepbound, Wegovy

Mangoceuticals (MGRX) announces that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to authentic Zepbou...

Nasdaq 5h
Here Are the Top Growth Healthcare Stocks Every New Investor Should Know

Key Points These two healthcare giants have impressive growth potential for different reasons. Eli Lilly is getting a lot of attention for its GLP-1 successes...

Here Are the Top Growth Healthcare Stocks Every New Investor Should Know
TipRanks 13h
Major Stock Movements: Eli Lilly & Co Shares Sold by Key Shareholder

New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 12, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help...

Nasdaq 24h
Ex-Dividend Reminder: Eli Lilly, Teleflex and Charles Schwab

Looking at the universe of stocks we cover at Dividend Channel, on 11/14/25, Eli Lilly (Symbol: LLY), Teleflex Incorporated (Symbol: TFX), and The Charles Schwa...

Ex-Dividend Reminder: Eli Lilly, Teleflex and Charles Schwab
The Motley Fool 1d
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence Stock

Recursion is about to go toe-to-toe with the largest healthcare company. Recursion Pharmaceuticals (RXRX 0.43%) has been a pioneer in using artificial intellig...

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence Stock

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.